Related Experiment Video
Updated: Jun 2, 2026

Measuring Psoriasis Severity at Home
Published on: March 1, 2024
Practical issues on interpretation of scoring atopic dermatitis: SCORAD Index, objective SCORAD, patient-oriented
1Department of Paediatrics, Paediatric Dermatology, Erasmus Medical Centre, Rotterdam, The Netherlands.
Insights
The SCORAD Index is a validated tool for atopic dermatitis (AD) assessment. Modifications have led to misuse, highlighting the need for standardized application and patient-centered evaluations.
Area of Science:
- Dermatology
- Clinical Assessment Tools
- Atopic Dermatitis Research
Background:
- The Scoring of Atopic Dermatitis (SCORAD) Index is the most validated scoring system for atopic dermatitis (AD).
- Previous modifications to the SCORAD Index have resulted in its incorrect application.
- Accurate assessment of AD severity is crucial for effective treatment and management.
Purpose of the Study:
- To clarify the correct application of the SCORAD Index for measuring atopic dermatitis extent and intensity.
- To discuss the components of the SCORAD Index, including objective and subjective measures.
- To introduce patient-oriented assessment tools and the Three-Item Severity (TIS) score for AD evaluation.
Main Methods:
- The SCORAD Index utilizes the rule of nines to assess lesion extent (0-100).
- Intensity is graded based on six items (erythema, edema, etc.) on a 0-3 scale.
- Subjective components include pruritus and sleeplessness, with a defined formula: A/5 + 7B/2 + C.
Main Results:
- The SCORAD Index has a maximal score of 103, with the objective component reaching 83.
- Patient-oriented SCORAD scores show good correlation with the SCORAD Index.
- The Three-Item Severity (TIS) score correlates well with the objective SCORAD and is suitable for epidemiological studies.
Conclusions:
- Standardized use of the SCORAD Index is essential to avoid misinterpretation.
- Patient well-being is paramount, necessitating patient-centered assessment tools.
- The TIS score offers a quick and effective method for AD prescreening and epidemiological research.
Abstract:
The SCORAD (Index) is the best validated scoring system in atopic dermatitis (AD). Modification of the SCORAD Index has led several times to incorrect use of the system. To measure the extent of AD, the rule of nines is applied on a front/back drawing of the patient's inflammatory lesions. The extent can be graded from 0 to 100. The intensity part of the SCORAD consists of 6 items: erythema, oedema/papulation, excoriations, lichenification, oozing/crusts and dryness. Each item can be graded on a scale from 0 to 3. The subjective items include daily pruritus and sleeplessness. The SCORAD Index formula is: A/5 + 7B/2 + C. In this formula A is defined as the extent (0-100), B is defined as the intensity (0-18) and C is defined as the subjective symptoms (0-20). The maximal score of the SCORAD Index is 103. The objective SCORAD consist of the extent and the intensity items; the formula is A/5 + 7B/2. The maximal objective SCORAD score is 83 (with 10 additional points for severe disfiguring eczema of the face and hands). Patients should also evaluate their dermatitis, because their well-being is the most important aspect of treating AD. Therefore different self-assessment scores for AD patients, including the patient-oriented SCORAD, were developed. The patient-oriented SCORAD correlates well with the SCORAD Index. The Three-Item Severity (TIS) score involves the scoring of erythema (redness), oedema and excoriations (scratches) in one representative lesion. The TIS score corresponds well with the objective SCORAD and can be used as prescreening system or as a quick system in studies and is excellent for epidemiological studies.
More Related Videos
09:32Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
06:29Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
Published on: May 25, 2022